Quick Answer
Hepion Pharmaceuticals, Inc. reported Shares Outstanding of 11.62 million shares for fiscal year 2025.
Hepion Pharmaceuticals, Inc. Shares Outstanding — Annual History
| Fiscal Year | Shares Outstanding | YoY Change |
|---|---|---|
| 2025 | 11.62M | +8249.8% |
| 2024 | 139,168 | +44.4% |
| 2023 | 96,375 | -97.5% |
| 2022 | 3.81M | -95.0% |
| 2021 | 76.23M | +138.0% |
| 2020 | 32.03M | +751.7% |
| 2019 | 3.76M | +1422.3% |
| 2018 | 247,013 | -97.5% |
| 2017 | 9.79M | -87.1% |
| 2017 | 75.71M | +134.9% |
| 2016 | 32.23M | +44.7% |
| 2015 | 22.28M | +20.5% |
| 2014 | 18.48M | +105.3% |
| 2013 | 9.00M | +0.0% |
| 2012 | 9.00M | — |
Quarterly Shares Outstanding
| Quarter Ending | Shares Outstanding | YoY | QoQ |
|---|---|---|---|
| September 30, 2025 | 11.62M | +67.0% | +0.0% |
| June 30, 2025 | 11.62M | +100.4% | +21.2% |
| March 31, 2025 | 9.59M | +75.2% | +6790.2% |
| December 31, 2024 | 139,168 | -97.1% | -98.0% |
| September 30, 2024 | 6.96M | +81.3% | +20.0% |
| June 30, 2024 | 5.80M | +51.1% | +6.0% |
| March 31, 2024 | 5.47M | +43.6% | +13.6% |
| December 31, 2023 | 4.82M | +26.4% | +25.5% |
- Hepion Pharmaceuticals, Inc. showed an increase of +8249.8% in Shares Outstanding compared to the prior fiscal year.
- Over the 2012–2025 period, Hepion Pharmaceuticals, Inc.’s shares outstanding has grown by 29.1% (from 9.00 million shares to 11.62 million shares).
- The most recent figure is from Hepion Pharmaceuticals, Inc.’s fiscal year 2025 report (Form 10-K), filed with the SEC on March 12, 2026.
- All figures are sourced from SEC EDGAR XBRL filings, last verified June 17, 2026.
Last verified: